PD-1-Fc-OX40L fusion protein simultaneously blocks immune checkpoint pathways and activates TNFRs Jan. 18, 2019
FDA accepts IND for phase Ib/IIa study of Hyleukin-7 with atezolizumab in high-risk skin cancers Jan. 17, 2019
ADC Therapeutics begins phase I trial of ADCT-601 in advanced or metastatic solid tumors Jan. 17, 2019
Pharmaxis eyes phase II studies with LOXL2 inhibitors following completion of toxicity studies Jan. 17, 2019
RSS